(Q24243272)

1

0 references

Michael Farrell

object named as

Michael Farrell

2

0 references

author name string

Reinhard Bornemann

3

0 references

Lynn E Sullivan

Cochrane Database of Systematic Reviews

4

0 references

publication date

23 April 2008

0 references

published in

0 references

cites work

Retrospective analyses of additional services for methadone maintenance patients.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004145.PUB3

AIDS risk behavior in opioid dependent patients treated with community reinforcement approach and relationships with psychiatric disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004145.PUB3

Community reinforcement approach in the treatment of opiate addicts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004145.PUB3

Day treatment versus enhanced standard methadone services for opioid-dependent patients: a comparison of clinical efficacy and cost

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004145.PUB3

Gender, cocaine and during-treatment HIV risk reduction among injection opioid users in methadone maintenance

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004145.PUB3

Maintenance of HIV risk reduction among injection opioid users: a 12 month posttreatment follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004145.PUB3

Gender differences at admission and follow-up in a sample of methadone maintenance clients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004145.PUB3

A randomised controlled trial of methadone maintenance treatment versus wait list control in an Australian prison system

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004145.PUB3

Four-year follow-up of imprisoned male heroin users and methadone treatment: mortality, re-incarceration and hepatitis C infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004145.PUB3

Reduction or cessation of injecting risk behaviours? Treatment outcomes at 1-year follow-up.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004145.PUB3

The National Treatment Outcome Research Study (NTORS): 4-5 year follow-up results

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004145.PUB3

Patterns of improvement after methadone treatment: 1 year follow-up results from the National Treatment Outcome Research Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004145.PUB3

Reduced injection risk and sexual risk behaviours after drug misuse treatment: results from the National Treatment Outcome Research Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004145.PUB3

HIV risk behaviors among women in methadone maintenance treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004145.PUB3

Ethnic differences in HIV risk behaviors, self-perceptions, and treatment outcomes among women in methadone maintenance treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004145.PUB3

Influence of psychiatric comorbidity on HIV risk behaviors: changes during drug abuse treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004145.PUB3

HIV risk behaviors during pharmacologic treatment for opioid dependence: a comparison of levomethadyl acetate [corrected] buprenorphine, and methadone

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004145.PUB3

Changes in Cocaine Use After Entry to Methadone Treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004145.PUB3

A randomized clinical trial of a manual-guided risk reduction intervention for HIV-positive injection drug users.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004145.PUB3

Profiles of self-reported HIV-risk behaviors among injection drug users in methadone maintenance treatment, detoxification, and needle exchange programs

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004145.PUB3

Buprenorphine treatment for opioid dependence: the relative efficacy of daily, twice and thrice weekly dosing

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004145.PUB3

HIV infection and cocaine use in methadone maintained and untreated intravenous drug users.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004145.PUB3

Changes in HIV risk behaviors among patients receiving combined pharmacological and behavioral interventions for heroin and cocaine dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004145.PUB3

Methadone maintenance vs 180-day psychosocially enriched detoxification for treatment of opioid dependence: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004145.PUB3

Methadone treatment as a determinant of HIV risk reduction among injecting drug users: a nested case-control study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004145.PUB3

Client engagement and change during drug abuse treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004145.PUB3

Methadone maintenance treatment and HIV risk-taking behaviour among injecting drug users in Berlin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004145.PUB3

Randomized trial of supervised injectable versus oral methadone maintenance: report of feasibility and 6-month outcome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004145.PUB3

One year outcomes for heroin dependence: findings from the Australian Treatment Outcome Study (ATOS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004145.PUB3

Methadone treatment and HIV and hepatitis B and C risk reduction among injectors in the Seattle area

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004145.PUB3

Methadone maintenance treatment and HIV type 1 seroconversion among injecting drug users

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004145.PUB3

Targeting HIV-related outcomes with intravenous drug users maintained on methadone: a randomized clinical trial of a harm reduction group therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004145.PUB3

Risk Factors and predictors of human immunodeficiency virus infection among injection drug users

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004145.PUB3

Patients successfully maintained with methadone escaped human immunodeficiency virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004145.PUB3

Reduction of AIDS risk among 41 heroin addicted female street prostitutes: effects of free methadone maintenance

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004145.PUB3

Drug injection cessation among HIV-infected injecting drug users

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004145.PUB3

HIV infection risks, behaviors and methadone treatment: client-reported HIV infection in a follow-up study of injecting drug users in New England

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004145.PUB3

Methadone maintenance and the likelihood of risky needle-sharing.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004145.PUB3

Drug use, injecting practices and sexual behaviour of opioid users in Sydney, Australia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004145.PUB3

Antisocial personality disorder, HIV risk behavior and retention in methadone maintenance therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004145.PUB3

Validity of intravenous drug abusers' self-reported changes in HIV high-risk drug use behaviors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004145.PUB3

Correlates of drug injection behaviors among methadone outpatients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004145.PUB3

Methadone maintenance and cessation of injecting drug use: results from the Amsterdam Cohort Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004145.PUB3

Trends in HIV risk behaviour and methadone dosage among HIV-negative drug users: an ecological study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004145.PUB3

Methadone maintenance and needle/syringe sharing

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004145.PUB3

Sex, drugs and HIV counseling and testing: a prospective study of behavior-change among methadone-maintenance clients in New England

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004145.PUB3

Changes in HIV risk behaviors among cocaine-using methadone patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004145.PUB3

Comparison of pharmacological treatments for opioid-dependent adolescents: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004145.PUB3

Behavioural change in injecting drug users: evaluation of an HIV/AIDS education programme.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004145.PUB3

Binge drug use independently predicts HIV seroconversion among injection drug users: implications for public health strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004145.PUB3

Risk dimensions of HIV-tested substance users

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004145.PUB3

Antiretroviral adherence and HIV treatment outcomes among HIV/HCV co-infected injection drug users: the role of methadone maintenance therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004145.PUB3

Methadone treatment in the Scottish context: outcomes of a community-based service for drug users in Lothian

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004145.PUB3

Longitudinal changes in injection behaviors in a cohort of injection drug users

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004145.PUB3

Risk factors for human immunodeficiency virus infection in intravenous drug users

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004145.PUB3

Methadone maintenance and other factors associated with intraindividual temporal trends in injection-drug use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004145.PUB3

History of syringe sharing in prison and risk of hepatitis B virus, hepatitis C virus, and human immunodeficiency virus infection among injecting drug users in Berlin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004145.PUB3

Infectious diseases and public health: risk-taking behavior during participation in the Swiss program for a medical prescription of narcotics (PROVE).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004145.PUB3

Sex differences in risk factors for hiv seroconversion among injection drug users: a 10-year perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004145.PUB3

High-risk sexual behaviors of intravenous drug users in- and out-of-treatment: implications for the spread of HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004145.PUB3

Retention in methadone maintenance is associated with reductions in different HIV risk behaviors for women and men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004145.PUB3

Methadone treatment and risk of HIV infection in drug users without legal access to clean injection equipment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004145.PUB3

Adherence to methadone is associated with a lower level of HIV-related risk behaviors in drug users

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004145.PUB3

Syringe-mediated drug sharing among injecting drug users: patterns, social context and implications for transmission of blood-borne pathogens

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004145.PUB3

Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004145.PUB3

Medical care for injection-drug users with human immunodeficiency virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004145.PUB3

Adherence to HIV treatment among IDUs and the role of opioid substitution treatment (OST).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004145.PUB3

AIDS and injecting drug use in the United Kingdom, 1987-1993: the policy response and the prevention of the epidemic

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004145.PUB3

The Privatization of Methadone Maintenance; Changes in Risk Behavior Associated with Cost Related Detoxification

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004145.PUB3

Impact of drug maintenance treatment on injection practices among French HIV-infected IDUs

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004145.PUB3

A Morphine Prescription Program in Italy (1980-1985): Retrospective Evidence of Protection Against Hiv/Aids

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004145.PUB3

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004145.PUB3

Heroin use and HIV risk-taking behaviour among women injecting drug users

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004145.PUB3

A Low Threshold Methadone Stabilisation Programme–Description and First Stage Evaluation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004145.PUB3

Patterns of Heroin, Cocaine and Speedball Injection Among Bronx (Usa) Methadone Maintenance Patients: 1978-1988

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004145.PUB3

Outcomes of a 21-Day Drug Detoxification Program: Retention, Transfer to Further Treatment, and HIV Risk Reduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004145.PUB3

HIV incidence among injection drug users in New York City, 1992-1997: evidence for a declining epidemic

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004145.PUB3

Short-term Outcomes for the Treatment of Heroin Dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004145.PUB3

Comparing opiate users in methadone treatment with untreated opiate users: results of a follow-up study with a Toronto opiate user cohort.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004145.PUB3

7 January 2021

Levels of intravenous drug misuse among clients prescribed oral dexamphetamine or oral methadone: a comparison

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004145.PUB3

7 January 2021

What happens when a demonstration project ends. Consequences for a clinic and its clients

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004145.PUB3

7 January 2021

Sex, drugs, and HIV: does methadone maintenance reduce drug use and risky sexual behavior?

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004145.PUB3

7 January 2021

When is less treatment better? The role of social anxiety in matching methadone patients to psychosocial treatments

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004145.PUB3

7 January 2021

Methadone maintenance treatment reduces heroin injection in New South Wales prisons

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004145.PUB3

7 January 2021

Methadone maintenance treatment modalities in relation to incidence of HIV: results of the Amsterdam cohort study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004145.PUB3

7 January 2021

Reduced infections with HIV and hepatitis A during a Swiss intravenous opiate maintenance program

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004145.PUB3

7 January 2021

Methadone maintenance as HIV risk reduction with street-recruited injecting drug users

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004145.PUB3

7 January 2021

The sharing of injecting equipment among drug users attending prescribing clinics and those using needle-exchanges

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004145.PUB3

7 January 2021

Antisocial personality disorder and HIV infection among intravenous drug abusers

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004145.PUB3

7 January 2021

Drug abuse treatment as HIV prevention: changes in social drug use patterns might also reduce risk

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004145.PUB3

7 January 2021

HIV prevalence and risk behavior among injecting drug users who participate in "low-threshold" methadone programs in Amsterdam

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004145.PUB3

7 January 2021

Risk factors for HIV-1 seroconversion among injection drug users: a case-control study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004145.PUB3

7 January 2021

Retention, HIV risk, and illicit drug use during treatment: methadone dose and visit frequency

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004145.PUB3

7 January 2021

A Controlled Trial of Methadone Maintenance in a Population of Intravenous Drug Users in Bangkok: Implications for Prevention of HIV

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004145.PUB3

7 January 2021

Reducing HIV risk behavior among injection drug users: effect of methadone maintenance treatment on number of sex partners

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004145.PUB3

7 January 2021

Feasibility of prescribing injectable heroin and methadone to opiate-dependent drug users: associated health gains and harm reductions.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004145.PUB3

7 January 2021

10.1002/14651858.CD004145.PUB3

Identifiers

DOI

1 reference

Consolidated OpenCitations Corpus – April 2017

2482412

2482412

1 reference

Consolidated OpenCitations Corpus – April 2017

Consolidated OpenCitations Corpus – April 2017

1 reference